Global Osteoporosis Drugs Market Research Report 2016

October 2016 | 117 pages | ID: GC6CDEC2A2AEN
QYResearch

Abstracts

Notes:

Production, means the output of Osteoporosis Drugs

Revenue, means the sales value of Osteoporosis Drugs

This report studies Osteoporosis Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Novartis
• Merck & Co
• Eli Lilly
• Amgen
• Abiogen Pharma
• Deltanoid Pharmaceuticals
• F. Hoffmann La Roche
• GlaxoSmithKline
• IMMD
• Ligand Pharmaceuticals
• NPS Pharma
• Pantarhei Bioscience
• Pfizer
• PhytoHealth
• Radius Health
• Shenzhen Haiwang
• Kunming Baker Norton
• Chia Tai Tianqing

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Osteoporosis Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Antiresorptive Medications
• Anabolic Medications
• Others

Split by application, this report focuses on consumption, market share and growth rate of Osteoporosis Drugs in each application, can be divided into

• Hospital use
• Clinic use
• Others

Contents

Global Osteoporosis Drugs Market Research Report 2016

1 OSTEOPOROSIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Osteoporosis Drugs
1.2 Osteoporosis Drugs Segment by Type
  1.2.1 Global Production Market Share of Osteoporosis Drugs by Type in 2015
  1.2.2 Antiresorptive Medications
  1.2.3 Anabolic Medications
  1.2.4 Others
1.3 Osteoporosis Drugs Segment by Application
  1.3.1 Osteoporosis Drugs Consumption Market Share by Application in 2015
  1.3.2 Hospital use
  1.3.3 Clinic use
  1.3.4 Others
1.4 Osteoporosis Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Osteoporosis Drugs (2011-2021)

2 GLOBAL OSTEOPOROSIS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Osteoporosis Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Osteoporosis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Osteoporosis Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Osteoporosis Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Osteoporosis Drugs Market Competitive Situation and Trends
  2.5.1 Osteoporosis Drugs Market Concentration Rate
  2.5.2 Osteoporosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL OSTEOPOROSIS DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Osteoporosis Drugs Production and Market Share by Region (2011-2016)
3.2 Global Osteoporosis Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL OSTEOPOROSIS DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Osteoporosis Drugs Consumption by Regions (2011-2016)
4.2 North America Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Osteoporosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL OSTEOPOROSIS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Osteoporosis Drugs Production and Market Share by Type (2011-2016)
5.2 Global Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Osteoporosis Drugs Price by Type (2011-2016)
5.4 Global Osteoporosis Drugs Production Growth by Type (2011-2016)

6 GLOBAL OSTEOPOROSIS DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Osteoporosis Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Osteoporosis Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL OSTEOPOROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Osteoporosis Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Novartis Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Merck & Co
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Osteoporosis Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Merck & Co Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Osteoporosis Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Eli Lilly Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Osteoporosis Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Amgen Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Abiogen Pharma
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Osteoporosis Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Abiogen Pharma Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Deltanoid Pharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Osteoporosis Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Deltanoid Pharmaceuticals Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 F. Hoffmann La Roche
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Osteoporosis Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 F. Hoffmann La Roche Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 GlaxoSmithKline
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Osteoporosis Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 GlaxoSmithKline Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 IMMD
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Osteoporosis Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 IMMD Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Ligand Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Osteoporosis Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Ligand Pharmaceuticals Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 NPS Pharma
7.12 Pantarhei Bioscience
7.13 Pfizer
7.14 PhytoHealth
7.15 Radius Health
7.16 Shenzhen Haiwang
7.17 Kunming Baker Norton
7.18 Chia Tai Tianqing

8 OSTEOPOROSIS DRUGS MANUFACTURING COST ANALYSIS

8.1 Osteoporosis Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Osteoporosis Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Osteoporosis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL OSTEOPOROSIS DRUGS MARKET FORECAST (2016-2021)

12.1 Global Osteoporosis Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Osteoporosis Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Osteoporosis Drugs Production Forecast by Type (2016-2021)
12.4 Global Osteoporosis Drugs Consumption Forecast by Application (2016-2021)
12.5 Osteoporosis Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoporosis Drugs
Figure Global Production Market Share of Osteoporosis Drugs by Type in 2015
Figure Product Picture of Antiresorptive Medications
Table Major Manufacturers of Antiresorptive Medications
Figure Product Picture of Anabolic Medications
Table Major Manufacturers of Anabolic Medications
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Osteoporosis Drugs Consumption Market Share by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Others Examples
Figure North America Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Osteoporosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Osteoporosis Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Osteoporosis Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Osteoporosis Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoporosis Drugs Production Share by Manufacturers
Figure 2016 Osteoporosis Drugs Production Share by Manufacturers
Table Global Osteoporosis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Osteoporosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Osteoporosis Drugs Revenue Share by Manufacturers
Table 2016 Global Osteoporosis Drugs Revenue Share by Manufacturers
Table Global Market Osteoporosis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Osteoporosis Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Osteoporosis Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Osteoporosis Drugs Product Type
Figure Osteoporosis Drugs Market Share of Top 3 Manufacturers
Figure Osteoporosis Drugs Market Share of Top 5 Manufacturers
Table Global Osteoporosis Drugs Production by Regions (2011-2016)
Figure Global Osteoporosis Drugs Production and Market Share by Regions (2011-2016)
Figure Global Osteoporosis Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Osteoporosis Drugs Production Market Share by Regions
Table Global Osteoporosis Drugs Revenue by Regions (2011-2016)
Table Global Osteoporosis Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Osteoporosis Drugs Revenue Market Share by Regions
Table Global Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Osteoporosis Drugs Consumption Market by Regions (2011-2016)
Table Global Osteoporosis Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Osteoporosis Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Osteoporosis Drugs Consumption Market Share by Regions
Table North America Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table China Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table India Osteoporosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Osteoporosis Drugs Production by Type (2011-2016)
Table Global Osteoporosis Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Osteoporosis Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Osteoporosis Drugs by Type
Table Global Osteoporosis Drugs Revenue by Type (2011-2016)
Table Global Osteoporosis Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Osteoporosis Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Osteoporosis Drugs by Type
Table Global Osteoporosis Drugs Price by Type (2011-2016)
Figure Global Osteoporosis Drugs Production Growth by Type (2011-2016)
Table Global Osteoporosis Drugs Consumption by Application (2011-2016)
Table Global Osteoporosis Drugs Consumption Market Share by Application (2011-2016)
Figure Global Osteoporosis Drugs Consumption Market Share by Application in 2015
Table Global Osteoporosis Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Osteoporosis Drugs Consumption Growth Rate by Application (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Osteoporosis Drugs Market Share (2011-2016)
Table Merck & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co Osteoporosis Drugs Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Osteoporosis Drugs Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Osteoporosis Drugs Market Share (2011-2016)
Table Abiogen Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abiogen Pharma Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abiogen Pharma Osteoporosis Drugs Market Share (2011-2016)
Table Deltanoid Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Deltanoid Pharmaceuticals Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Deltanoid Pharmaceuticals Osteoporosis Drugs Market Share (2011-2016)
Table F. Hoffmann La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann La Roche Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann La Roche Osteoporosis Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Osteoporosis Drugs Market Share (2011-2016)
Table IMMD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IMMD Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure IMMD Osteoporosis Drugs Market Share (2011-2016)
Table Ligand Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ligand Pharmaceuticals Osteoporosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ligand Pharmaceuticals Osteoporosis Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoporosis Drugs
Figure Manufacturing Process Analysis of Osteoporosis Drugs
Figure Osteoporosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
Table Major Buyers of Osteoporosis Drugs
Table Distributors/Traders List
Figure Global Osteoporosis Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Osteoporosis Drugs Production Forecast by Regions (2016-2021)
Table Global Osteoporosis Drugs Consumption Forecast by Regions (2016-2021)
Table Global Osteoporosis Drugs Production Forecast by Type (2016-2021)
Table Global Osteoporosis Drugs Consumption Forecast by Application (2016-2021)